BR112012026768A2 - composições compreendendo pró-farmacos de opioides cliváveis de modo enzimático e seus inibidores. - Google Patents

composições compreendendo pró-farmacos de opioides cliváveis de modo enzimático e seus inibidores.

Info

Publication number
BR112012026768A2
BR112012026768A2 BR112012026768A BR112012026768A BR112012026768A2 BR 112012026768 A2 BR112012026768 A2 BR 112012026768A2 BR 112012026768 A BR112012026768 A BR 112012026768A BR 112012026768 A BR112012026768 A BR 112012026768A BR 112012026768 A2 BR112012026768 A2 BR 112012026768A2
Authority
BR
Brazil
Prior art keywords
prodrug
compositions
inhibitors
enzymatically cleavable
enzymatically
Prior art date
Application number
BR112012026768A
Other languages
English (en)
Inventor
Craig O Husfeld
Jonathan W Wray
Julie D Seroogy
Thomas E Jenkins
Original Assignee
Signature Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Signature Therapeutics Inc filed Critical Signature Therapeutics Inc
Publication of BR112012026768A2 publication Critical patent/BR112012026768A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Abstract

composições compreendendo pró-farmacos de opioides cliváveis de modo enzimático e seus inibidores. a presente revelação provê composições farmacêuticas e seus métodos de utilização, em que as composições farmacêuticas compreendem um pró-fármaco que provê a liberação controlada de modo enzimático de um pró-fármaco e um inibidor enzimático que interage com a(s) enzima(s) que medeia(m) a liberação controlada de modo enzimático do pró-fármaco a partir do pró-fármaco, de modo atenuar a clivagem enzimática do pró-fármaco. a revelação provê composições farmacêuticas que compreendem um inibidor enzimático e um pró-fármaco que contém uma fração clivável de modo enzimático que, quando clivada, facilita a liberação do pró-fármaco.
BR112012026768A 2010-04-21 2010-04-21 composições compreendendo pró-farmacos de opioides cliváveis de modo enzimático e seus inibidores. BR112012026768A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2010/031953 WO2011133149A1 (en) 2010-04-21 2010-04-21 Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof

Publications (1)

Publication Number Publication Date
BR112012026768A2 true BR112012026768A2 (pt) 2015-09-29

Family

ID=44834413

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012026768A BR112012026768A2 (pt) 2010-04-21 2010-04-21 composições compreendendo pró-farmacos de opioides cliváveis de modo enzimático e seus inibidores.

Country Status (9)

Country Link
EP (1) EP2560489A4 (pt)
JP (1) JP2013525348A (pt)
CN (1) CN102917589A (pt)
AU (1) AU2010351605C1 (pt)
BR (1) BR112012026768A2 (pt)
CA (1) CA2795222A1 (pt)
IL (1) IL222354A0 (pt)
RU (1) RU2012149438A (pt)
WO (1) WO2011133149A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011031350A1 (en) * 2009-09-08 2011-03-17 Pharmacofore, Inc. Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
ES2584634T3 (es) * 2011-01-11 2016-09-28 Signature Therapeutics, Inc. Composiciones que comprenden un profármaco de oxicodona escindible enzimáticamente
US11634384B2 (en) 2014-11-25 2023-04-25 Concentric Analgesics, Inc. Prodrugs of phenolic TRPV1 agonists
US20170056352A1 (en) 2015-08-25 2017-03-02 Rgenix, Inc. PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
EP3463576A4 (en) 2016-05-25 2020-01-15 Concentric Analgesics, Inc. PRODRUGS BY PHENOLIC TRPV1 AGONISTS IN COMBINATION WITH LOCAL ANESTHETIC AND VASOCONSTRICTORS FOR IMPROVED LOCAL ANESTHESIA
WO2018160178A1 (en) 2017-03-01 2018-09-07 Rgenix, Inc. Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof
EP3684417A1 (en) * 2017-09-19 2020-07-29 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Lipophilic peptide prodrugs
EP3684785A1 (en) 2017-09-19 2020-07-29 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. N-methylated cyclic peptides and their prodrugs
US10717712B2 (en) 2018-07-27 2020-07-21 Concentric Analgesics, Inc. Pegylated prodrugs of phenolic TRPV1 agonists
US11806405B1 (en) 2021-07-19 2023-11-07 Zeno Management, Inc. Immunoconjugates and methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4668418B2 (ja) * 1998-12-15 2011-04-13 アプライド バイオシステムズ リミテッド ライアビリティー カンパニー 多種酵素アッセイ
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US8163701B2 (en) * 2005-08-19 2012-04-24 Signature Therapeutics, Inc. Prodrugs of active agents
CA2624179A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
CN101528264B (zh) * 2006-05-26 2014-02-26 特色疗法股份有限公司 酚类阿片样物质的受控释放
MX2008014794A (es) * 2006-05-26 2009-04-08 Pharmacofore Inc Liberacion controlada de opioides fenolicos.
WO2008101187A2 (en) * 2007-02-16 2008-08-21 Pharmacofore, Inc. Pro-drugs of peripheral phenolic opioid antagonists
BRPI0919711A2 (pt) * 2008-10-17 2015-12-08 Pharmacofore Inc composições farmacêuticas com liberação atenuada de opióides fenólicos
WO2011031350A1 (en) * 2009-09-08 2011-03-17 Pharmacofore, Inc. Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof

Also Published As

Publication number Publication date
AU2010351605A1 (en) 2012-11-22
WO2011133149A1 (en) 2011-10-27
AU2010351605C1 (en) 2015-08-06
EP2560489A1 (en) 2013-02-27
JP2013525348A (ja) 2013-06-20
CN102917589A (zh) 2013-02-06
RU2012149438A (ru) 2014-05-27
CA2795222A1 (en) 2011-10-27
IL222354A0 (en) 2012-12-31
AU2010351605B2 (en) 2015-01-29
EP2560489A4 (en) 2014-01-22

Similar Documents

Publication Publication Date Title
BR112012026768A2 (pt) composições compreendendo pró-farmacos de opioides cliváveis de modo enzimático e seus inibidores.
WO2012122420A3 (en) Opioid prodrugs with heterocyclic linkers
WO2012096887A3 (en) Compositions comprising enzyme-cleavable oxycodone prodrug
WO2012122422A3 (en) Active agent prodrugs with heterocyclic linkers
JO3450B1 (ar) أشكال جرعات تحرير جديدة معدلة لمثبطات زانثين اوكسيدوريدوكتيز أو مثبطات زانثين اوكسيديز
PH12016501668A1 (en) Compositions and methods for the reduction or prevention of hepatic steatosis
BR112012009135A2 (pt) composição polímera termoplástica
NI201400078A (es) Derivados de lactamas útiles como inhibidores mutantes de idh1
CR20110467A (es) Derivados de benzofuranilo como inhibidores de la glucoquinasa
WO2012142498A3 (en) Mif inhibitors and their uses
BR112015018783A2 (pt) mistura íntima seca, composição, método de preparação de uma mistura íntima seca e método de aumento da germinação, crescimento, metabolismo e/ou atividade enzimática de esporos bacterianos
CR20130267A (es) Inhibidores de nampt y rock
UA93533C2 (en) Insecticidal composition
GT201100322A (es) Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10a
BRPI0900060A2 (pt) método e sistema para fabricar um artigo
SG179026A1 (en) Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
BR112012019529A2 (pt) inibidores de d-nitrosoglutationa redutase
WO2012122412A3 (en) Compositions for reducing risk of adverse events caused by drug-drug interactions
WO2013003298A3 (en) Inhibitors of pde10
MX2012008738A (es) Microorganismos y metodos para la biosintesis de p-toluato y tereftalato.
BR112014004319A2 (pt) compostos e composições como inibidores de c-kit cinase
BR112013031307A2 (pt) métodos para tratamento de material lignocelulósico
IN2012DN02093A (pt)
BR112013033557A2 (pt) aditivo adesivo
BR112014011357A2 (pt) método de perfuração usando quebrador enzimático de manano-hidrolase

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]